Bide Pharmatech Co Ltd (688073)

Shanghai

Currency in CNY

67.00

+10.70(+19.01%)

Closed·06:59:59

Fair Value

Unlock Value

Day's Range

56.16

67.56

52 wk Range

43.21

88.88

Bide Pharmatech (688073) Income Statement & Profits

Assess the Bide Pharmatech income statement (earnings report) to see how the company performs across operating and non-operating activities, including revenue, expenses and net income. Review 688073 diluted EPS and profitability over the last four annual or quarterly periods.

Investors who need greater depth or who want to customise how data is presented to fit their own investment styles are able to do so via their very own InvestingPro account.

Period Ending:

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

606.22

833.83

1,091.86

1,102.01

1,323.81

Total Revenues Growth

aa.aa

+54.86%

+37.55%

+30.94%

+0.93%

+20.13%

Cost Of Revenues

aa.aa

315.89

471.29

673.38

680.35

773.33

Gross Profit

aa.aa

290.33

362.54

418.48

421.66

550.48

Gross Profit Growth

aa.aa

+42.22%

+24.87%

+15.43%

+0.76%

+30.55%

Gross Profit Margin %

aa.aa

47.89%

43.48%

38.33%

38.26%

41.58%

Other Operating Expenses, Total

aa.aa

182.75

218.2

319.18

308.68

362.81

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	+42.74%	+19.4%	+46.28%	-3.29%	+17.54%
aa.aa	aa.aa	aa.aa	32.1	43.46	59.72	55.62	59.44
aa.aa	aa.aa	aa.aa	148.22	170.78	254.45	246.63	298.1
aa.aa	aa.aa	aa.aa	2.42	3.96	5.01	6.43	5.27

Operating Income

aa.aa

107.58

144.34

99.3

112.99

187.67

Operating Income Growth

aa.aa

+41.36%

+34.16%

-31.21%

+13.79%

+66.1%

EBIT Margin %

aa.aa

17.75%

17.31%

9.09%

10.25%

14.18%

Net Interest Expenses

aa.aa

2.97

6.7

29.21

20.43

13.54

Net Interest Expenses Growth

aa.aa

+366.42%

+125.27%

+335.93%

-30.08%

-33.71%

Interest Expense, Total

aa.aa

-0.92

-2.16

-2.53

-3.32

-5.8

Interest And Investment Income

aa.aa

3.9

8.86

31.74

23.74

19.34

Other Non Operating Expenses, Total

aa.aa

-7.76

10.31

3.43

0.87

-20.04

EBT, Excl. Unusual Items

aa.aa

102.8

161.35

131.95

134.28

181.17

Gain (Loss) On Sale Of Assets

aa.aa

7.92

0.44

1.15

3.9

Other Unusual Items, Total

aa.aa

3.83

10.88

6.24

9.44

9.69

EBT, Incl. Unusual Items

aa.aa

114.56

171.77

126

148.02

195.43

EBT, Incl. Unusual Items Growth

aa.aa

+63.02%

+49.94%

-26.65%

+17.48%

+32.03%

EBT, Incl. Unusual Items Margin

aa.aa

18.9%

20.6%

11.54%

13.43%

14.76%

Income Tax Expense

aa.aa

16.99

25.8

17.55

30.59

43.69

Net Income to Company

aa.aa

97.57

145.97

108.45

117.43

151.74

Minority Interest

aa.aa

1.13

Net Income

aa.aa

97.57

145.97

109.57

117.43

151.74

Net Income Growth

aa.aa

+65.37%

+49.6%

-24.94%

+7.17%

+29.22%

Net Income Margin %

aa.aa

16.1%

17.51%

10.04%

10.66%

11.46%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

97.57

145.97

109.57

117.43

151.74

Basic EPS - Continuing Operations

aa.aa

1.46

1.98

1.21

1.32

1.75

Basic EPS - Continuing Operations Growth

aa.aa

+53.07%

+35.89%

-38.89%

+9.09%

+32.58%

Diluted EPS - Continuing Operations

aa.aa

1.46

1.98

1.21

1.32

1.73

Diluted EPS - Continuing Operations Growth

aa.aa

+53.38%

+35.89%

-38.89%

+9.09%

+31.06%

Basic Weighted Average Shares Outstanding

aa.aa

66.96

73.72

90.56

88.96

86.71

Diluted Weighted Average Shares Outstanding

aa.aa

66.96

73.72

90.56

88.96

87.71

Dividend Per Share

aa.aa

1.1

0.9

1.16

Dividend Per Share Growth

aa.aa

-18.18%

+28.89%

EBITDA

aa.aa

111.51

150.15

108.85

124.12

201.88

EBITDA Growth

aa.aa

+41.89%

+34.65%

-27.5%

+14.03%

+62.64%

EBITDA Margin %

aa.aa

18.39%

18.01%

9.97%

11.26%

15.25%

EBIT

aa.aa

107.58

144.34

99.3

112.99

187.67

* In Millions of CNY (except for per share items)

FAQ

What was the quarter-over-quarter change in EBITDA for Bide Pharmatech?

688073's EBITDA changed by 63.31% compared to the last quarter.

How did Bide Pharmatech’s revenue change compared to the previous quarter?

Revenue changed by 2.47% compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Bide Pharmatech?

In the latest quarter, Bide Pharmatech's gross profit changed by 21.34%.

FTSE 100

10,729.78

+7.71

+0.07%

DAX

25,818.75

-220.93

-0.85%

Euro Stoxx 50

6,130.85

-76.22

-1.23%

S&P 500

7,572.11

-148.28

-1.92%

Nikkei 225

63,290.11

-1,369.36

-2.12%

Dow Jones

51,828.56

-514.00

-0.98%

FTSE 100 Futures

10,735.50

-21.0

-0.20%

Market Movers

Name	Last	Chg. %	Vol.
AstraZeneca	13,960.0	+6.96%	4.46M
Anglo American	3,704.0	-4.17%	9.27M
Shell	4,036.5	-0.04%	8.15M
Lloyds Banking	93.50	-5.23%	298.61M
GSK plc	1,855.00	+2.26%	13.55M
NatWest Group	579.60	-8.75%	38.77M
HSBC	1,277.00	-1.21%	16.84M

Name	Last	Chg. %	Vol.
National Bank of Greece	15.890	+472.20%	180.00
Trane Technologies	414.98	+370.66%	2.21K
ALK-Abello	248.30	+66.14%	20.55K
BW LPG	230.65	+46.63%	17.66K
Piraeus Bank	9.720	+39.86%	329.00
Quadrise	1.450	+34.26%	14.35M
Oracle Power	0.039	+30.00%	236.62M

Name	Last	Chg. %	Vol.
GCM Resources	6.75	-48.08%	19.94M
Cloudbreak Discovery	0.22	-41.18%	189.20M
Predator Oil	0.80	-39.85%	48.68M
Trafalgar	11.50	-28.13%	8.36K
Marley Spoon	0.03	-25.00%	0.00
Petra Diamonds	2.30	-23.33%	503.41K
capAI	0.35	-18.60%	5.44M

Trending Stocks

Name	Last	Chg. %	Vol.
NatWest Group	579.60	-8.75%	38.77M
Lloyds Banking	93.50	-5.23%	298.61M
Reliance Industries Ltd DRC	49.55	+1.43%	78.78K
Rolls-Royce Holdings	1,239.40	-3.17%	15.12M
BP	627.40	+0.50%	28.16M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaa	402.60	+41.87%	571.15
Aaaaaaaaaaaa Aaa	465.90	+41.03%	657.04
A A Aaaaaa	538.40	+35.72%	730.73
A Aaaaaa	2,987.0	+33.57%	3,989.8
Aaa Aaaaaa	1,040.00	+32.34%	1,376.39
Aa Aaaaaaaaaaaaaaa	319.40	+32.08%	421.87
Aaaaaaaaa A	2,235.00	+30.15%	2,908.87

Name	Last	Upside	Fair Value
Aaaaaaaaa	402.60	+41.87%	571.15
Aaaaaaaaaaaa Aaa	465.90	+41.03%	657.04
A A Aaaaaa	538.40	+35.72%	730.73
A Aaaaaa	2,987.0	+33.57%	3,989.8
Aaa Aaaaaa	1,040.00	+32.34%	1,376.39
Aa Aaaaaaaaaaaaaaa	319.40	+32.08%	421.87
Aaaaaaaaa A	2,235.00	+30.15%	2,908.87

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.